[1]石洲宝,刘海涛△,刘成松,等.安神胶囊治疗精神分裂症患者睡眠障碍临床研究[J].西部中医药,2017,30(03):5-8.
 SHI Zhoubao,LIU Haitao,LIU Chengsong,et al.Clinicof the Patients Suffering from Schizophreniaal Study of AnShen Capsules in Treating Sleep Disorders[J].Western Journal of Traditional Chinese Medicine,2017,30(03):5-8.
点击复制

安神胶囊治疗精神分裂症患者睡眠障碍临床研究()
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
30
期数:
2017年03期
页码:
5-8
栏目:
论著·临床论著
出版日期:
2017-03-15

文章信息/Info

Title:
Clinicof the Patients Suffering from Schizophreniaal Study of AnShen Capsules in Treating Sleep Disorders
文章编号:
1004-6852(2017)03-0005-04
作者:
石洲宝刘海涛△刘成松刘敏科陈长浩
甘肃中医药大学附属医院,甘肃 兰州 730020
Author(s):
SHI Zhoubao LIU Haitao△ LIU Chengsong LIU Minke CHEN Changhao
Affiliated Hospital of Gansu University of Traditional Chinese Medicine, Lanzhou 730020, China
关键词:
精神分裂症睡眠障碍安神胶囊右佐匹克隆
Keywords:
schizophrenia sleep disorders AnShen capsules eszopiclone
分类号:
R256.2
文献标志码:
A
摘要:
目的:评价安神胶囊治疗精神分裂症患者睡眠障碍的临床疗效和安全性。方法:采用随机、对照的研究方法,将精神分裂症睡眠障碍患者222例分为对照组和治疗组各111例;治疗组口服安神胶囊,4粒/次,3次/d;对照组口服右佐匹克隆1.5~3 mg/d;2组均治疗6周;于治疗前及治疗后1、2、4、6周末评价睡眠评定量表(SDRS)及阳性与阴性症状量表(PANSS)疗效;并通过药物副作用量表(TESS)、临床总体印象量表(CGI)得分评价药物的安全性。结果:2组患者SDRS、PANSS总分和CGI在治疗第1周末开始下降,2组治疗后比较差异均有统计学意义(P<0.01);治疗结束时2组SDRS减分率治疗组为(75±23)%,对照组为(75±29)%,2组比较差异无统计学意义(P>0.05);PANSS有效率治疗组为78.3%,对照组为85.3%,2组比较差异无统计学意义(P>0.05);右佐匹克隆常见的副反应为轻度头昏、口苦、便秘等,治疗组视力模糊和严重度频度低于对照组(P<0.05)。结论:安神胶囊治疗精神分裂症患者睡眠障碍的临床疗效与右佐匹克隆相似,但不良反应发生率低。
Abstract:
Objective: To evaluate the clinical effect and safety of AnShen capsules in treating sleep disorders of patients with schizophrenia. Methods: With random and controlled study methods, 222 patients with sleep disorders were divided into the control group and the treatment group, 111 cases in each group. The treatment group was treated by orally taking AnShen Capsules, four capsules once, three times/d; and the control group was treated by orally taking eszopiclone, 1.5~3 mg/d, and both groups were treated for six weeks. The treating effects were evaluated by Sleep dysfunction rating scale (SDRS) and Positive and Negative Syndrome Scale (PANSS) before the intervention and the weekends of 1 st, 2 nd, 3 rd and 6th week after the intervention. And the drug safety was evaluated by scores of treatment emergent symptom scale (TESS) and clinical global impression scale (CGI). Results: Total scores of SDRS and PANSS, and CGI of patients in two groups began to decrease in the weekend of the 1st week treatment, after the treatment, the differences between two groups were statistically significant(P<0.01). At the end of the treatment, SDRS deduction rate of the treatment group was (75±23)%, and that of the control group was (75±29)%,and the differences were not statistically significant (P>0.05). PANSS effective rate of the treatment group was 78.3%, and that of the control group was 85.3%, the differences were not statistically significant (P>0.05). Eszopiclone had common side effects such as mild dizziness, bitterness in the mouth and constipation, and the side effects occurrence rate of AnShen capsules was significantly less than that of the eszopiclone group (P<0.05).Conclusion: Clinical effect of AnShen capsules in the treatment of sleep disorders of the patients with schizophrenia is close to that of eszopiclone, but the adverse event rate of the AnShen capsules is low.

相似文献/References:

[1]丁劲,施兴艳.中医护理干预对肝阳上亢型高血压睡眠障碍的影响*[J].西部中医药,2013,26(10):115.
 DING Jin,SHI Xingyan.Effects of TCM Nursing Intervention on Sleep Disorder Induced by Hypertension of Liver Yang Hyperactivity Pattern[J].Western Journal of Traditional Chinese Medicine,2013,26(03):115.
[2]徐伟,王守东△.耳穴埋籽加放松疗法对肿瘤患者睡眠质量障碍的影响[J].西部中医药,2014,27(03):115.
 XU Wei,Wang Shoudong.Effects of Ear Acupoint Pressing Method and Relax Therapy on Sleep Disorder of Cancer Patients[J].Western Journal of Traditional Chinese Medicine,2014,27(03):115.
[3]石洲宝,陈长浩,高娜,等.安神二号胶囊对慢性精神分裂症患者认知和社会功能的影响[J].西部中医药,2015,28(04):1.
[4]张淑萍,阮学平,段红梅,等.中医药治疗精神分裂症的文献引文分析[J].西部中医药,2015,28(05):69.
[5]周玉英,李向丽,潘虹,等.抑郁症睡眠障碍患者中医辨证施护效果观察[J].西部中医药,2015,28(07):149.
[6]李晓萍,张祖萍,马海英.耳穴磁珠贴压护理法对血液透析合并睡眠障碍患者睡眠质量的影响[J].西部中医药,2015,28(11):123.
[7]王润泽,任俊赏.涤痰汤联合哌罗匹隆治疗首发精神分裂症30例[J].西部中医药,2017,30(02):89.
 WANG Runze,REN Junshang.DiTan Tang Combined with Perospirone in Treating 30 Cases of First Episode Schizophrenia[J].Western Journal of Traditional Chinese Medicine,2017,30(03):89.
[8]祁霞珍,秦松杰,胡赟△.通督调神针法配合中医护理对脑卒中后睡眠障碍的影响[J].西部中医药,2016,29(05):113.
 QI Xiazhen,QIN Songjie,HU Yun.The Influence of Needling Method of Opening up Governor Meridian and Regulating Spirit Combined with TCM Care on Sleep Disorder of the Patients with Stroke[J].Western Journal of Traditional Chinese Medicine,2016,29(03):113.
[9]张永国,郭晓娟△.中药汤剂联合阿立哌唑治疗慢性精神分裂症59例[J].西部中医药,2017,30(12):88.
 ZHANG Yonguo,GUO Xiaojuan.Herbal Decoction Combined with Aripiprazole in Treating 59 Cases of Chronic Schizophrenia[J].Western Journal of Traditional Chinese Medicine,2017,30(03):88.
[10]单建华,孙 菡,罗 新.引导式教育训练对长期住院精神分裂症患者的影响[J].西部中医药,2018,31(08):120.
 SHAN Jianhua,SUN Han,LUO Xin.Effects of Directed Training on Long-stay Schizophrenics[J].Western Journal of Traditional Chinese Medicine,2018,31(03):120.

备注/Memo

备注/Memo:
收稿日期:2016-06-07*基金项目:甘肃省卫生行业科研管理项目(编号GWGL2014-17)。作者简介:石洲宝(1965—),男,硕士研究生导师,主任医师。研究方向:精神(心理)障碍的临床研究。△通讯作者:刘海涛(1964—),男,主任医师。研究方向:中医内科学。
更新日期/Last Update: 2017-03-15